Literature DB >> 21071465

Predictive factors for multiple sclerosis in patients with clinically isolated spinal cord syndrome.

Aurélie Ruet1, Mathilde S A Deloire, Jean-Christophe Ouallet, Sandrine Molinier, Bruno Brochet.   

Abstract

OBJECTIVES: To identify predictors of conversion to definite multiple sclerosis (MS) in patients with a cord clinically isolated syndrome.
METHODS: The predictive values for conversion to MS of clinical, magnetic resonance imaging (MRI) and cerebrospinal fluid (CSF) variables in 114 patients with acute partial myelitis confirmed by a spinal cord lesion on MRI were studied. Other causes of cord syndromes were excluded.
RESULTS: MS was diagnosed in 78 patients (86%) during 4.0 ± 1.9 years of follow-up. Some 67 of these patients had a second clinical episode. The diagnosis of isolated myelitis was maintained for 36 patients, 78% of whom (28 cases) were followed for at least 2 years, comparable to the MS patients. Age, bladder involvement, ≥ 2 cord lesions on MRI, ≥ 9 brain lesions, ≥ 3 periventricular lesions and intrathecal IgG synthesis predicted conversion to clinically definite MS. Multivariate logistic analysis identified three predictors of MS diagnosis: age ≤ 40 years, inflammatory CSF and ≥ 3 periventricular lesions on brain MRI.
CONCLUSION: Two out of three baseline factors (age, periventricular lesions and inflammatory CSF) predicted conversion to MS with better accuracy than the revised McDonald criteria for dissemination in space.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21071465     DOI: 10.1177/1352458510386999

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  9 in total

Review 1.  [Clinically isolated syndrome].

Authors:  M Platten; T Lanz; M Bendszus; R Diem
Journal:  Nervenarzt       Date:  2013-10       Impact factor: 1.214

2.  Should the symptomatic region be included in dissemination in space in MRI criteria for MS?

Authors:  Wallace J Brownlee; Josephine K Swanton; Katherine A Miszkiel; David H Miller; Olga Ciccarelli
Journal:  Neurology       Date:  2016-07-15       Impact factor: 9.910

3.  MRI of acute optic neuritis (ON) at the first episode: Can we predict the visual outcome and the development of multiple sclerosis (MS)?

Authors:  Michaela Cellina; Chiara Floridi; Cristina Rosti; Marcello Orsi; Marta Panzeri; Marta Pirovano; Matteo Ciocca; Giancarlo Oliva; Daniele Gibelli
Journal:  Radiol Med       Date:  2019-08-21       Impact factor: 3.469

4.  Predicting outcome in clinically isolated syndrome using machine learning.

Authors:  V Wottschel; D C Alexander; P P Kwok; D T Chard; M L Stromillo; N De Stefano; A J Thompson; D H Miller; O Ciccarelli
Journal:  Neuroimage Clin       Date:  2014-12-04       Impact factor: 4.881

Review 5.  MRI criteria for the diagnosis of multiple sclerosis: MAGNIMS consensus guidelines.

Authors:  Massimo Filippi; Maria A Rocca; Olga Ciccarelli; Nicola De Stefano; Nikos Evangelou; Ludwig Kappos; Alex Rovira; Jaume Sastre-Garriga; Mar Tintorè; Jette L Frederiksen; Claudio Gasperini; Jacqueline Palace; Daniel S Reich; Brenda Banwell; Xavier Montalban; Frederik Barkhof
Journal:  Lancet Neurol       Date:  2016-01-26       Impact factor: 44.182

Review 6.  The Role of B Cells in Primary Progressive Multiple Sclerosis.

Authors:  Jameson P Holloman; Robert C Axtell; Nancy L Monson; Gregory F Wu
Journal:  Front Neurol       Date:  2021-06-07       Impact factor: 4.086

7.  Predictors of Conversion to Multiple Sclerosis in Patients with Clinical Isolated Syndrome Using the 2010 Revised McDonald Criteria.

Authors:  R Alroughani; J Al Hashel; S Lamdhade; S F Ahmed
Journal:  ISRN Neurol       Date:  2012-11-01

8.  Idiopathic acute transverse myelitis: outcome and conversion to multiple sclerosis in a large series.

Authors:  Alvaro Cobo Calvo; M Alba Mañé Martínez; Agustí Alentorn-Palau; Jordi Bruna Escuer; Lucía Romero Pinel; Sergio Martínez-Yélamos
Journal:  BMC Neurol       Date:  2013-10-03       Impact factor: 2.474

9.  Evolution from a first clinical demyelinating event to multiple sclerosis in the REFLEX trial: Regional susceptibility in the conversion to multiple sclerosis at disease onset and its amenability to subcutaneous interferon beta-1a.

Authors:  Marco Battaglini; Hugo Vrenken; Riccardo Tappa Brocci; Giordano Gentile; Ludovico Luchetti; Adriaan Versteeg; Mark S Freedman; Bernard M J Uitdehaag; Ludwig Kappos; Giancarlo Comi; Andrea Seitzinger; Dominic Jack; Maria Pia Sormani; Frederik Barkhof; Nicola De Stefano
Journal:  Eur J Neurol       Date:  2022-04-04       Impact factor: 6.288

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.